PTC Therapeutics
PTCT
#2691
Rank
A$9.33 B
Marketcap
A$112.58
Share price
0.57%
Change (1 day)
44.57%
Change (1 year)

PTC Therapeutics (PTCT) - Total debt

Total debt on the balance sheet as of March 2026 : A$0.56 Billion

According to PTC Therapeutics 's latest financial reports the company's total debt is A$0.56 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

PTC Therapeutics - Total debt on balance sheet (from 2012 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$4.04 B1.73%
2024-12-31A$3.97 B21.42%
2023-12-31A$3.27 B52.34%
2022-12-31A$2.14 B22.66%
2021-12-31A$1.75 B220.22%
2020-12-31A$0.54 B16.7%
2019-12-31A$0.46 B115.71%
2018-12-31A$0.21 B16.97%
2017-12-31A$0.18 B36.28%
2016-12-31A$0.13 B8.07%
2015-12-31A$0.12 B
2014-12-31N/A-100%
2013-12-31A$0.05 M-98.83%
2012-12-31A$4.69 M-58.78%
2011-12-31A$11.4 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
A$66.99 B 11,795.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
A$2.83 B 402.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.26 B-52.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$1.47 B 162.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.11 B-79.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
A$70.2 M-87.53%๐Ÿ‡บ๐Ÿ‡ธ USA